SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on Capricors 24-month HOPE-3 open-label extension data for deramiocel, with traders highlighting the reported slowing of upper-limb decline after placebo patients switched to treatment. Bulls see the findings as added support for FDA approval, while skeptics question whether the analyses address the FDAs concerns about the trials statistical plan.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns upcoming quarterly earnings report is the dominant focus, with traders watching whether strong AI-driven memory demand, tight DRAM and NAND supply, and pricing momentum carry into its outlook. Bulls expect strong results and guidance, while skeptics argue high expectations may already be priced in and question how long the memory cycle can last, leaving debate centered on a possible rally versus a sell-the-news reaction.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FICO is under pressure after the FHFA moved to put VantageScore alongside FICO in mortgage pricing, with Rocket Mortgage also signaling a preference for VantageScore on eligible loans. Traders are debating whether this marks a lasting erosion of FICOs mortgage-scoring advantage and pricing power or an overreaction, with some selling on competition concerns and others viewing the sharp drop as a buying opportunity.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is under pressure amid competition from Kalshi and Polymarket and uncertainty over how prediction markets will be regulated; community discussion also points to scrutiny over reports alleging AI-driven promotions targeted losing bettors. Bears worry about market-share losses and rising investment costs, while bulls argue DKeX growth and sportsbook momentum could offset the spending.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

A DEA administrative judges pause of the broader cannabis rescheduling case to consider adding a GAO report has delayed a closely watched Schedule III catalyst for MSOS and its U.S. cannabis holdings. Traders are split between calling the selloff an overreaction to a procedural delay and worrying that the pause could push rescheduling further out; the pause does not overturn the separate medical-marijuana rule.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Positive Phase 3 results for Vandas HETLIOZ in delayed sleep-wake phase disorder are driving attention, with traders celebrating the study outcome and speculating about further gains. Others are cautious about whether the news can sustain the share move, amid ongoing concerns about cash burn and the companys execution.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Anticipation of NASAs CLPS 2.0 contract awards is driving discussion, with traders tracking repeated delays and speculating about potential awards for Intuitive Machines. Bulls view the decision as a possible catalyst, while others are frustrated by the uncertainty and weak, volatile trading alongside the broader space sector.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, attributed to stronger demand for Amtagvi, is driving the sharp rally, with analyst upgrades adding to the enthusiasm. Traders largely view the move as validation of the commercial ramp and speculate about short covering, while others warn of profit-taking and possible dilution.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhoods Summit product rolloutagentic AI trading tools, weekend/24/7 stock trading, expanded-hours options, and crypto perpetualsis driving attention as traders weigh the platforms growth potential against concerns about encouraging round-the-clock speculation. Reactions are mixed, with enthusiasm for the broader offering alongside criticism of the presentation and frustration that the stock has struggled to hold gains.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

A judges pause in the broader cannabis rescheduling case has delayed the next recommendation, prompting concern that a key catalyst for Trulieve and the sector may take longer. Traders are divided between viewing the delay as a reason for the selloff and seeing it as temporary, noting that the pause does not undo the earlier medical-marijuana rule.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


ETRF_Pod_3267

El Hefe de Etzatlan